Vacancy expired!
The CIMcare Study is testing an investigational drug to see whether it could help people with plaque psoriasis.
To qualify for the CIMcare Study, participants must:
Be 6–17 years of age
Have had moderate to severe plaque psoriasis for at least 6 months
Have a parent, caregiver or legal guardian to help them throughout the study
Other criteria must be met to qualify, which will be reviewed by the study team.
For further information about the CIMcare Study, contact our Care Access Rome study team at 706-252-3904.